These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 6542462

  • 21. Protective effects of a specific platelet activating factor (PAF) antagonist, WEB 2086, in traumatic shock.
    Stahl GL, Bitterman H, Lefer AM.
    Thromb Res; 1989 Feb 01; 53(3):327-38. PubMed ID: 2718150
    [Abstract] [Full Text] [Related]

  • 22. Protective effects of a novel thromboxane analog in lethal traumatic shock.
    Lefer AM, Araki H, Smith JB, Nicolaou KC, Magolda RL.
    Prostaglandins Med; 1979 Sep 01; 3(3):139-46. PubMed ID: 552102
    [Abstract] [Full Text] [Related]

  • 23. Effect of cyclooxygenase and thromboxane synthetase inhibition on furosemide-stimulated plasma renin activity.
    Datar S, McCauley FA, Wilson TW.
    Can J Physiol Pharmacol; 1987 Jan 01; 65(1):80-3. PubMed ID: 3105853
    [Abstract] [Full Text] [Related]

  • 24. Effects of adenosine, an adenosine-A1 antagonist, and their combination in splanchnic occlusion shock in rats.
    Karasawa A, Rochester JA, Lefer AM.
    Circ Shock; 1992 Feb 01; 36(2):154-61. PubMed ID: 1582007
    [Abstract] [Full Text] [Related]

  • 25. Protective action of a thromboxane synthetase inhibitor in preventing extension of infarct size in acute myocardial infarction.
    Hock CE, Phillips GR, Lefer AM.
    Prostaglandins Leukot Med; 1985 Mar 01; 17(3):339-46. PubMed ID: 3857643
    [Abstract] [Full Text] [Related]

  • 26. Involvement of brain thromboxane A in hypotension induced by haemorrhage in rats.
    Yalcin M, Cavun S, Yilmaz MS, Cengiz F, Savci V.
    Clin Exp Pharmacol Physiol; 2005 Nov 01; 32(11):960-7. PubMed ID: 16405453
    [Abstract] [Full Text] [Related]

  • 27. Protective effects of thromboxane receptor blockade in splanchnic artery occlusion shock.
    Aoki N, Lefer AM.
    Methods Find Exp Clin Pharmacol; 1988 Jul 01; 10(7):413-8. PubMed ID: 3419244
    [Abstract] [Full Text] [Related]

  • 28. The effect of beta-adrenoceptor blockade and of thromboxane synthetase inhibition, alone and in combination, on arrhythmias resulting from myocardial ischemia.
    Wainwright CL, Parratt JR.
    Adv Myocardiol; 1985 Jul 01; 6():573-84. PubMed ID: 4039460
    [Abstract] [Full Text] [Related]

  • 29. Protective effects of G 619, a dual thromboxane synthase inhibitor and thromboxane A2 receptor antagonist, in splanchnic artery occlusion shock.
    Squadrito F, Altavilla D, Zingarelli B, Ioculano MP, Campo GM, Calapai G, Saitta A, Urna G, Sardella A, Spignoli G.
    J Cardiovasc Pharmacol; 1992 Jan 01; 19(1):115-9. PubMed ID: 1375677
    [Abstract] [Full Text] [Related]

  • 30. Pharmacological characterization of FCE 27262, a combined thromboxane synthase inhibitor and PGH2/TXA2 receptor antagonist.
    Vaghi F, Colombo M, Pierucci L, Volpi D, Dho L, Ukmar G, Rosa B, Salvati P.
    Drugs Exp Clin Res; 1993 Jan 01; 19(6):249-60. PubMed ID: 8013268
    [Abstract] [Full Text] [Related]

  • 31. Cloricromene improves survival rate and peritoneal macrophage function in splanchnic artery occlusion shock in rats.
    Sturniolo R, Squadrito F, Altavilla D, Trimarchi GR, Prosdocimi M, Caputi AP.
    Circ Shock; 1989 Jul 01; 28(3):267-77. PubMed ID: 2766481
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Beneficial effects of oligotide, a novel oligodeoxyribonucleotide, in murine traumatic shock.
    Skurk C, Nuss C, Lefer AM.
    Shock; 1995 Jan 01; 3(1):13-20. PubMed ID: 7531603
    [Abstract] [Full Text] [Related]

  • 34. Protective effects of CG-4203, a novel stable prostacyclin analog, in traumatic shock.
    Bitterman H, Stahl GL, Lefer AM.
    Prostaglandins; 1988 Jan 01; 35(1):41-50. PubMed ID: 3287456
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Sodium 5-(3'-pyridinylmethyl)benzofuran-2-carboxylate (U-63557A), a new, selective thromboxane synthase inhibitor: intravenous and oral pharmacokinetics in dogs and correlations with ex situ thromboxane B2 production.
    Wynalda MA, Liggett WF, Fitzpatrick FA.
    Prostaglandins; 1983 Aug 01; 26(2):311-24. PubMed ID: 6685888
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Effects of a pyridine derivative thromboxane synthetase inhibitor and its inactive isomer in endotoxic shock in the rat.
    Anderegg K, Anzeveno P, Cook JA, Halushka PV, McCarthy J, Wagner E, Wise WC.
    Br J Pharmacol; 1983 Apr 01; 78(4):725-32. PubMed ID: 6687819
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.